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Hippocampal plasticity is triggered by a variety of stimuli including sensory inputs,
neurotrophins and inflammation. Leptin, whose primary function is to regulate food
intake and energy expenditure, has been recently shown to affect hippocampal
neurogenesis and plasticity. Interestingly, mice fed a high-fat diet (HFD) exhibit impaired
hippocampal function, but the underlying mechanisms are poorly understood. To
address this issue, we compared leptin responsiveness of hippocampal neurons in
control and HFD-fed mice by combining single-cell electrophysiology and biochemical
assays. We found that leptin modulated spontaneous and evoked synaptic transmission
in control, but not HFD, mice. This functional impairment was paralleled by blunted
activation of STAT-3, one of the key signal transduction pathways controlled by the
fully functional isoform of the leptin receptor, ObRb. In addition, SOCS-3 expression
was non-responsive to leptin, indicating that modulation of negative feedback impinging
on ObRb was also altered. Our results advance the understanding of leptin action on
hippocampal plasticity and, more importantly, suggest that leptin resistance is a key
determinant of hippocampal dysfunction associated with hypercaloric diet.
Keywords: patch-clamp, STAT-3, SOCS-3, ObR, CA1, Schaffer collateral
INTRODUCTION
The hippocampus plays a central role in learning and in the consolidation of new memories. This
function is accomplished through plasticity at both functional (i.e., synaptic transmission and
circuit activity) and structural (i.e., synapse remodeling and neurogenesis) levels. Hippocampal
plasticity is affected by a variety of modulators, including neurotrophins (Aicardi et al., 2004;
Conner et al., 2009), inflammatorymediators (Habbas et al., 2015) and other extracellular molecules
(e.g., extracellular matrix components; Dityatev et al., 2010). More recently, soluble factors involved
in metabolic signaling have been proposed to markedly affect hippocampal plasticity (Mainardi
et al., 2013, 2015). Among these, leptin is a notable example. It was first identified as the messenger
conveying signals about the status of long-term energy stores (i.e., white adipose tissue) and
satiation to the basal hypothalamus (Friedman and Halaas, 1998). However, expression of ObRb,
the fully functional isoform of leptin receptor, is not confined to cerebral nuclei involved in
metabolic homeostasis. Indeed, the hippocampus displays a strikingly high level of ObRb expression
(Scott et al., 2009; Caron et al., 2010). Accordingly, leptin has been shown tomodulate neurogenesis,
dendritic spine generation and synaptic transmission by activating the STAT-3, PI3 kinase and ERK
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signaling pathways (Coppari and Bjørbæk, 2012; Harvey, 2013),
thus exerting a neurotrophin-like action on the hippocampus.
Facilitation of plasticity is, in turn, correlated to improved
performance in behavioral tasks involving learning and memory
(Oomura et al., 2006; Morrison, 2009; Mainardi et al., 2015).
Moreover, leptin has neuroprotective effects in experimental
models of stroke (Zhang and Chen, 2008) and in transgenic mice
reproducing the key features of Alzheimer’s disease (AD; Pérez-
González et al., 2014).
The delicate balance regulating the action of leptin is altered
in rodents fed with a high-fat diet (HFD), which mimics
a hypercaloric Western-style diet (de Git and Adan, 2015).
This dietary regimen is responsible for the development of
insulin and leptin resistance, thus leading to obesity and type
II diabetes (Morrison et al., 2009; Balland and Cowley, 2015).
In addition to these metabolic consequences, several reports
point to impaired performance in learning and memory tasks
involving the hippocampus, such as the Morris water maze
(Boitard et al., 2014) and the novel object recognition test
(Heyward et al., 2012). Consistently, long-term depression (LTD)
and long-term potentiation (LTP) evoked at CA1 synapses are
impaired (Valladolid-Acebes et al., 2012; Hao et al., 2016).
Accumulating clinical evidence also points to a significant
negative effect of hypercaloric diet and obesity on cognitive
performance (Wang et al., 2016). To this regard, obesity is now
considered a risk factor for AD (McGuire and Ishii, 2016).
Despite the importance of the topic, the consequences of
HFD on hippocampal function have not been exhaustively
investigated. In the present work, we focused our attention
on the effects of leptin on the modulation of spontaneous
and evoked synaptic transmission at the Schaffer Collateral
(SC)-CA1 synapse. We found that HFD-fed mice failed to
display the enhancement of synaptic transmission that leptin
induced in mice fed a standard diet (SD). Parallel molecular
analyses revealed that the signaling pathways downstream ObRb
activation were impaired in HFD mice. Specifically, we found
decreased STAT-3 activation, and increased basal SOCS-3
expression that was no more responsive to leptin, thus indicating
an impairment of this negative feedback impinging on ObRb.
Our data support the view that leptin affects hippocampal
function and provide evidence that a HFD causes hippocampal
leptin resistance. These results can have important consequences
for the understanding the basis of impaired cognitive
performance in both animals and humans subjected to a
hypercaloric diet.
MATERIALS AND METHODS
Animals and Diet
Male C57BL/6 mice were weaned at postnatal (P) day 21 and fed
ad libitum with either a HFD (23% proteins; 42% carbohydrates,
namely 28% starch, 9% sucrose, 5% maltodextrin; 34% fats; 60%
fat caloric content; PF4051/D, Mucedola, Italy) or a standard
chow diet (SD; 18.5% proteins; 46% carbohydrates, namely
42% starch, 4% sucrose; 3% fats; 6.55% fat caloric content;
4RF21, Mucedola) for 8 weeks, then used for tissue collection
or electrophysiology experiments. The HFD regimen resulted
in overweight and hyperglycemia (Supplementary Figure S1).
Mice were housed under a 12-h light-dark cycle at constant
room temperature (22◦C). All animal procedures were approved
by the Ethics Committee of Catholic University and were
fully compliant with Italian (Ministry of Health guidelines,
Legislative Decree No. 26/2014) and European Union (Directive
No. 2010/63/UE) laws on animal research. The experiments were
carried out in strict accordance with the approved guidelines.
Electrophysiology and Data Analysis
For the preparation of brain slices, we followed the protocol
described in Curcio et al. (2013), with minor modifications.
Animals were euthanized by cervical dislocation and decapitated.
The brains were rapidly removed and placed in ice-cold,
sucrose-based cutting solution containing the following (inmM):
TRIS-HCl 72, TRIZMA base 18, NaH2PO4 1.2, NaHCO3 30,
KCl 2.5, glucose 25, HEPES 20, MgSO4 10, Na-pyruvate 3,
ascorbic acid 5, CaCl2 0.5, sucrose 20. Slices (300 µm thick) were
cut on a vibratome (VT1200S; Leica Microsystems, Germany)
and immediately transferred to an incubation chamber held at
32◦C and filled with a recovery solution containing (in mM):
TRIS-HCl 72, TRIZMA base 18, NaH2PO4 1.2, NaHCO3 25,
KCl 2.5, glucose 25, HEPES 20, MgSO4 10, Na-pyruvate 3,
ascorbic acid 5, CaCl2 0.5, sucrose 20. After 30 min, slices
were transferred to a second incubation chamber held at 32◦C
and filled with artificial cerebrospinal fluid (aCSF) containing
the following (in mM): NaCl 124, KCl 3.2, NaH2PO4 1.2,
MgCl2 1, CaCl2 2, NaHCO3 26 and glucose 10, pH 7.4.
During incubations, the chambers were continuously bubbled
with 95% O2/5% CO2. Finally, slices were equilibrated at RT
for at least 45 min. For electrophysiological recordings, slices
were transferred to a submerged recording chamber constantly
perfused with heated aCSF (32◦C) and bubbled with 95%
O2/5% CO2. Neurons of the CA1 area were visualized under
DIC infrared illumination. Stimulation of the SC was obtained
by means of a current stimulus isolator (WPI, Worcester,
MA, USA), connected to a bipolar concentric stimulating
electrode (FHC, Bowdoin, ME, USA) which was positioned in
contact with the SC pathway. Patch pipettes had a resistance
of 4–6 MΩ when filled with an internal solution containing
(in mM): K-gluconate 145, MgCl2 2, HEPES 10, EGTA 0.1,
Na-ATP 2.5, Na-GTP 0.25, phosphocreatine 5, pH adjusted
to 7.2 with KOH. For AMPA/NMDA ratio experiments, the
internal solution contained (in mM): CsCH3SO3 135, HEPES
10, NaCl 8, EGTA 0.25, MgCl2 2, Mg-ATP 4. Na-GTP
0.3, phosphocreatine 5, pH adjusted to 7.3 with NaOH. For
rectification index measurements, 0.1 mM spermine was added
to this solution. All the chemicals were purchased from Sigma-
Aldrich (Germany) and all the blockers from Tocris (USA),
unless otherwise stated. After establishing a gigaseal, the patch
was broken by applying negative pressure to achieve a whole-cell
configuration. A series resistance lower than 15 MΩ was
considered acceptable, and monitored constantly throughout
the entire recording. For evoked and spontaneous Excitatory
Postsynaptic Currents (EPSC) measurements, neurons were held
at −70 mV and electrical stimuli were delivered to the SC.
First, the input-output relationship was assessed in order to
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find the maximal response amplitude. Subsequent measurements
were performed using a stimulation that yielded 30% of the
maximal response. Paired-pulse facilitation (PPF) was assessed
by delivering pairs of stimuli at different interstimulus intervals
(ISIs; 20, 50, 100, 200 ms), repeated at 0.05 Hz. To obtain the
AMPA/NMDA currents ratio, stimuli of identical amplitude
were delivered at holding potentials of −70 and +40 mV,
as described in Ahmad et al. (2012), with a frequency of
0.05 Hz; 50 µM picrotoxin (PTX) was added to the bath.
Using this protocol, measurement of both currents with no
need to use pharmacological blockers could be obtained, thus
allowing their testing before and after leptin application. The
rectification index was calculated by recording the evoked EPSCs
at −60, −40, 0, +40 and +60 mV holding potentials in the
presence of 50 µMof the NMDA receptor blocker D-2-amino-5-
phosphonovalerate (D-AP5) and 50µMPTX, then by computing
the ratio (slope of the −60 to 0 mV regression line)/(slope of
the 0 to +60 mV regression line). The identity of evoked EPSCs
was confirmed at the end of the recordings by adding 10 µM
of the selective AMPA receptor blocker 2,3-Dioxo-6-nitro-
1,2,3,4-tetrahydrobenzo[f ]quinoxaline-7-sulfonamide (NBQX)
to the bath. For miniature EPSCs (mEPSCs) measurements,
0.5 µM tetrodotoxin and 50 µM PTX were applied to the
bath. After measuring the baseline parameters (i.e., maximum
AMPA response, AMPA/NMDA ratio, PPF, spontaneous EPSCs
(sEPSCs) or mEPSCs), murine leptin (Peprotech, UK) was
bath-applied at a 50 nM concentration, which has been
previously demonstrated to be the minimal dose required to
exert a maximal effect (Shanley et al., 2001; Luo et al., 2015).
After application, 10 min were allowed and measurements
were repeated. In control experiments, vehicle (saline) alone
was used. Recordings were performed using a Multiclamp
700B/Digidata 1550A system (Molecular Devices, Sunnyvale,
CA, USA) and digitized at a 10,000 Hz sampling frequency.
All the electrophysiological recordings were analyzed using the
Clampfit 10.6 software (Molecular Devices). AMPA receptor-
mediated EPSC amplitude was calculated as the difference
between the peak response and the baseline. NMDA receptor-
mediated EPSC amplitude was calculated as the amplitude 50 ms
after the response onset (Ahmad et al., 2012). For PPF analysis,
the ratio between the second and first evoked responses was
calculated. For mEPSC and sEPSC frequency analysis, a template
was constructed using the ‘‘Event detection/create template’’
function, as described in Ripoli et al. (2013). Then, mEPSCs
and sEPSCs were detected using the ‘‘Event detection/template
search’’ function; the ‘‘template match threshold’’ was set to
3.5 and the result inspected for false positives. For mEPSC and
sEPSC amplitude analysis, all the waveforms detected during a
single recording using template analysis were averaged and the
amplitude calculated. All the data are normalized as ((response
post-leptin application)/(baseline response))× 100.
Western Blotting and
Co-Immunoprecipitation
For in vivo administration, leptin was dissolved in saline and
i.p. injected (3 mg/kg), using an adaptation of the protocol
described in Mainardi et al. (2010). Mice were fasted for
2 h, injected and hippocampi dissected either 45 min or
2 h post-injection. Tissues were immediately frozen in liquid
nitrogen and stored at −80◦C until further processing. For
protein expression and phosphorylation, tissues were lysed in
ice-cold lysis buffer containing (in mM): NaCl 150, Tris-HCl
50 (pH 8), EDTA 2, NaF 1, Na3VO4 1, PMSF 1, 1% Triton
X-100, 1% SDS, 1X protease inhibitor mixture (Sigma-Aldrich,
Germany). After 15 min on ice, the lysates were centrifuged at
22,000 g, 4◦C to remove debris, and the supernatant quantified
for protein content (DC Protein Assay; Bio-Rad, USA). Equal
amounts of protein lysates were diluted in 6× Laemmli
buffer, boiled and resolved by SDS-PAGE, using either 12%
(STAT-3 and SOCS-3 detection) or 7% (ObRb detection)
acrylamide gels. Western blotting was performed by incubating
primary antibodies overnight at 4◦C with gentle rocking
and revealed with horseradish peroxidase-conjugated secondary
antibodies diluted at 1:5000 (7074 and 7076, Cell Signaling, USA;
sc-2020, Santa Cruz, USA). The following primary antibodies
were used: rabbit monoclonal anti-705Tyr-pSTAT-3 (1:1000,
Cell Signaling 9145), mouse monoclonal anti-STAT-3 (1:1000,
Cell Signaling 9139), mouse monoclonal anti-ObR (1:1000,
Santa Cruz sc-8391), goat polyclonal anti-1138Tyr-pObR (1:1000,
Santa Cruz sc-16421), rabbit polyclonal anti-473Ser-pAkt (1:1000,
Cell Signaling 4060), rabbit polyclonal anti-Akt (1:1000, Cell
Signaling 9272), rabbit polyclonal anti-SOCS-3 (1:1000, Cell
Signaling 2923), mouse monoclonal anti-α-tubulin (1:8000,
Sigma-Aldrich T5168), rabbit polyclonal anti-GluR1 (1:1000,
Cell Signaling D4N9V), mouse monoclonal anti-GluR2 (1:1000,
Millipore MAB391). For co-immunoprecipitation experiments,
tissues were lysed in low-detergent buffer containing (in mM):
KCl 50, Tris-HCl 50 (pH 8), EDTA 10 and 1% NP-40. Lysates
were centrifuged at 22,000 g to remove debris and a fraction of
the supernatant was used for assessing the quality of the total
lysate. Lysates were precleared for 30 min with empty protein
G-sepharose 4B beads (Sigma-Aldrich) before being challenged
with 1–2 µg of specific antibody (mouse anti-ObRb) or IgG
control and fresh protein G matrix. After a 6-h incubation at 4◦C
with a rotating mixer, protein-G-bound immunocomplexes were
collected by centrifugation (22,000 g, 1 min) andwashed six times
with 500 µl of immunoprecipitation buffer. Beads were finally
resuspended in 30 µL of 1× Laemmli buffer and boiled. Eluted
proteins were subjected to SDS-PAGE and immunoblotting as
described above. Blots were imaged and analyzed using an
Alliance imaging platform (Uvitec, UK) and the optical densities
were normalized as follows: (phosphoprotein ‘‘X’’)/(total levels
of protein ‘‘X’’)/(α-tubulin) and (total levels of protein ‘‘X’’)/(α-
tubulin). For each experimental replica, data were normalized
on the average relative optical density of the control group
(i.e., SD-veh).
Statistical Analyses
Data were analyzed using the SigmaPlot 12 software (Systat,
USA). Statistical significance was assessed using one- or two-way
analysis of variance (ANOVA-1 and -2, respectively), with factor
1 = diet (i.e., SD or HFD) and factor 2 = treatment (i.e., leptin
or vehicle). When a significant interaction was detected, groups
were compared using Bonferroni post hoc test. For comparisons
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between SD and HFD groups only, Student’s t test was used.
Statistically significant differences between mEPSC cumulative
distributions were assessed using Kolmogorov-Smirnov test.
Data are expressed as mean± SEM.
RESULTS
HFD Mice did Not Exhibit Leptin-Driven
Enhancement of Spontaneous
Neurotransmitter Release
Administration of leptin to cultured hippocampal neurons has
been reported to increase both frequency and amplitude of
mEPSCs (Dhar et al., 2014). First, we checked whether a similar
effect was observed in hippocampus brain slices obtained from
adult mice fed a SD. Voltage-clamp experiments revealed that
administration of leptin increased the frequency of mEPSCs
from 1.34 ± 0.11 Hz to 2.35 ± 0.23 Hz (Figures 1A,B).
Accordingly, the cumulative frequency distribution for
interevent intervals was shifted to the left after treatment
with leptin (Figure 1D). A significant enhancement of mEPSC
amplitude, from 10.15 ± 0.43 pA to 13.68 ± 0.99 pA, was
also observed (Figures 1A,C). Consistent with this finding,
the cumulative frequency distribution of event amplitudes was
shifted to the right after leptin treatment (Figure 1E). A different
picture emerged when we performed similar measurements
on hippocampal slices obtained from mice fed a HFD. Indeed,
leptin failed to alter both mEPSC frequency and amplitude,
which amounted to 1.17 ± 0.19 Hz (baseline 1.27 ± 0.21 Hz)
and 10.62 ± 0.65 pA (baseline 11.03 ± 0.63 pA), respectively
(Figures 1A–C). In keeping with this, the corresponding
cumulative frequency distributions before and after leptin
treatment were superimposable (Figures 1D,E). The baseline
frequencies of mEPSCs were not significantly different among
the four experimental groups (SD-veh, 1.44 ± 0.17 Hz;
SD-lep, 1.34 ± 0.11 Hz; HFD-veh, 1.37 ± 0.23 Hz; HFD-lep,
FIGURE 1 | Leptin modulates spontaneous neurotransmitter release in standard diet (SD), but not in high-fat diet (HFD), mice. (A) Representative traces showing
miniature excitatory postsynaptic current (mEPSC) recordings in SD and HFD mice treated with vehicle or leptin; both baseline and post-treatment (i.e., vehicle or
leptin) recordings, corresponding to the same cell, are shown. (B) mEPSC frequency is increased in SD mice in response to leptin application; in contrast, HFD mice
are resistant to this effect (SD-veh n = 13, SD-lep n = 11, HFD-veh n = 11, HFD-lep n = 14; analysis of variance (ANOVA)-2 diet × treatment interaction p = 0.009,
followed by Bonferroni post hoc test, ∗∗p = 0.002, ∗∗∗p < 0.001). (C) SD mice display higher mEPSC amplitude in response to leptin application, whereas HFD mice
fail to respond to the treatment (SD-veh n = 13, SD-lep n = 11, HFD-veh n = 11, HFD-lep n = 14; ANOVA-2, diet × treatment interaction, p = 0.007, followed by
Bonferroni post hoc test, ##p = 0.006, ∗∗p = 0.005, ∗∗∗p < 0.001). (D) Cumulative frequency distributions for mEPSC interevent intervals, showing a leftwards shift for
SD-lep mice (blue curve, upper right panel, Kolmogorov-Smirnov test, p = 0.035) in contrast to no shift in HFD-lep mice (red curve, lower right panel,
Kolmogorov-Smirnov test, p = 0.95). (E) Cumulative frequency distributions for mEPSC amplitude, showing a rightwards shift for SD-lep mice (blue curve, upper
right panel, Kolmogorov-Smirnov test, p = 0.01) in contrast to no shift in HFD-lep mice (red curve, lower right panel, Kolmogorov-Smirnov test, p = 0.42).
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1.27 ± 0.21 Hz; ANOVA-2, pdiet = 0.713, ptreatment = 0.589,
pinteraction = 0.974). The same observation emerged from
analysis of mEPSC amplitudes (SD-veh, 10.20 ± 0.50 pA;
SD-lep, 10.15 ± 0.43 pA; HFD-veh, 11.23 ± 0.72 pA;
HFD-lep, 11.03 ± 0.63 pA; ANOVA-2, pdiet = 0.100,
ptreatment = 0.825, pinteraction = 0.896). To better address the point
of neurotransmitter release, we also recorded sEPSCs, i.e., by
omitting PTX and tetrodotoxin from the bath (see ‘‘Materials
and Methods’’ Section). In the SD-lep group, leptin caused the
sEPSC frequency to rise from 1.73 ± 0.18 Hz to 2.57 ± 0.27 Hz,
whereas in the HFD-lep group it remained to 1.69 ± 0.24 Hz
(baseline 1.88 ± 0.25 Hz; Supplementary Figures S2A,B). On
the other hand, no significant effects were found on sEPSC
amplitude in both SD-lep and HFD-lep groups (SD-lep, baseline
13.76 ± 1.40 pA, post-leptin 13.74 ± 1.44 pA; HFD-lep, baseline
11.74 ± 0.79 pA, post-leptin 11.05 ± 0.88 pA; ANOVA-2,
pdiet = 0.523, ptreatment = 0.750, pinteraction = 0.989). Also in
this case, the baseline frequencies (SD-veh, 1.71 ± 0.18 Hz;
SD-lep, 1.73 ± 0.18 Hz; HFD-veh, 1.73 ± 0.23 Hz; HFD-lep,
1.88 ± 0.25 Hz; ANOVA-2, pdiet = 0.585, ptreatment = 0.828,
pinteraction = 0.589) and amplitudes (SD-veh, 13.22 ± 1.53 pA;
SD-lep, 13.76 ± 1.40 pA; HFD-veh, 12.04 ± 1.00 pA; HFD-lep,
11.74 ± 0.79 pA; ANOVA-2, pdiet = 0.358, ptreatment = 0.863,
pinteraction = 0.958) were not significantly different among the
four groups. The trend towards a reduced sEPSC amplitude
in HFD mice, compared to SD mice, was also non-significant
(Supplementary Figures S2A,C).
These data show that leptin affects basal synaptic transmission
at CA3-CA1 synapses in adult SD mice, and that this effect is lost
in HFD mice.
HFD Mice Failed to Potentiate Evoked
EPSCs and PPF in Response to Leptin
Administration
The amplitude of currents evoked by stimulation of
SC afferents to CA1 neurons is potentiated by leptin
application, thus resulting in a long-lasting, LTP-like effect
(Moult and Harvey, 2011). By performing voltage-clamp
EPSC recordings, we confirmed that this effect was also
observed in our experimental conditions. Indeed, leptin
application to slices obtained from SD mice induced a
potentiation of EPSC amplitude in CA1 neurons reaching
169 ± 12% of baseline (Figures 2A,B). However, no
significant changes in EPSC amplitude (103 ± 9% of
baseline) were induced by leptin in brain slices of HFD
mice (Figures 2A,B).
Expression of synaptic plasticity involves changes in the
ratio between AMPA receptor- and NMDA receptor-mediated
EPSCs (Ahmad et al., 2012). To investigate whether leptin
affected this parameter, we performed EPSC recordings by
alternatively switching between −70 mV and +40 mV holding
potentials (see ‘‘Materials and Methods’’ Section). In slices
obtained from SD mice, CA1 neurons responded to leptin
with an increase in the AMPA/NMDA EPSC ratio from
1.59 ± 0.21 to 3.76 ± 1.02 (Figures 2C,D). Instead, in slices
obtained from HFD mice, the AMPA/NMDA EPSC ratio
was not significantly affected by leptin (baseline, 1.65 ± 0.30,
post-leptin, 1.79 ± 0.30; Figures 2C,D). This effect was a
consequence of the potentiation of AMPA receptor-mediated
EPSCs in SD mice only (SD-veh, 105.11 ± 7.37%; SD-lep,
170.12 ± 13.18%; HFD-veh 107.51 ± 14.80%; HFD-lep,
111.29 ± 10.76% of baseline value; ANOVA-2, diet × treatment
interaction, p = 0.013, followed by Bonferroni post hoc
test, SD-lep vs. SD-veh, p < 0.001, SD-lep vs. HFD-lep,
p = 0.002), whereas no significant difference in NMDA
receptor-mediated EPSCs before and after leptin application
was detected (SD-veh, 82.44 ± 8.182%; SD-lep, 91.19 ± 31.58%;
HFD-lep, 89.97 ± 10.33%; HFD-lep, 98.35 ± 14.59% of
baseline value; ANOVA-2, pdiet = 0.699, ptreatment = 0.652,
pinteraction = 0.992). The basal AMPA/NMDA ratio was not
significantly different among the four experimental groups
(SD-veh, 1.44± 0.15; SD-lep, 1.50± 0.21; HFD-veh, 1.62± 0.16;
HFD-lep, 1.65± 0.30; ANOVA-2, pdiet = 0.416, ptreatment = 0.829,
pinteraction = 0.948). Addition of the selective AMPA blocker
NBQX abolished the inward evoked currents described
above, thus confirming the identity of the recorded EPSCs
(Supplementary Figure S3).
The effects on synaptic plasticity and transmission prompted
us to address whether leptin could also affect short-term
plasticity of the SC-CA1 pathway. We approached this point
using the paired-pulse protocol, by delivering electrical stimuli
to the SC at ISIs of 20, 50, 100 and 200 ms (see ‘‘Materials
and Methods’’ Section). When pairs of stimuli at low ISIs
(i.e., 20 and 50 ms) were delivered to CA1 neurons of SD
mice, we did not observe any significant effect on PPF in
response to leptin application (Supplementary Figure S4). This
finding is in line with previous literature reports (Moult
et al., 2009). Interestingly, a significant increase in PPF was
found at longer ISIs (from 1.76 ± 0.12 to 2.23 ± 0.18,
and from 1.38 ± 0.12 to 1.90 ± 0.19 for 100 and 200 ms
ISI, respectively, Figure 3). Also in this case, in slices
from HFD mice leptin failed to elicit any significant change
in PPF at all ISIs we examined (from 1.85 ± 0.08 to
1.70 ± 0.14, and from 1.62 ± 0.07 to 1.43 ± 1.12 for
100 and 200 ms ISI, respectively; Figure 3). The basal PPF
values did not differ among the four experimental groups
for both 100 ms (SD-veh, 1.56 ± 0.11; SD-lep, 1.76 ± 0.12;
HFD-veh, 1.76 ± 0.12; HFD-lep, 1.85 ± 0.08; ANOVA-2,
pdiet = 0.178, ptreatment = 0.177, pinteraction = 0.588) and
200 ms (SD-veh, 1.41 ± 0.1; SD-lep, 1.377 ± 0.12; HFD-veh,
1.45 ± 0.08; HFD-lep, 1.62 ± 0.07; ANOVA-2, pdiet = 0.129,
ptreatment = 0.458, pinteraction = 0.249) ISI. These effects do not
appear to be due to a difference in the AMPA rectification
index, which was 1.36 ± 0.24 in SD mice and 1.33 ± 0.21 in
HFD mice (Supplementary Figures 5A–C). In keeping with
this, the GluR1 and GluR2 AMPA receptor subunits levels
were not significantly different between SD and HFD mice
(Supplementary Figures 5D–F).
Taken together, these results show that leptin is able to
modulate both spontaneous and evoked neurotransmission at
the SC-CA1 pathway. Notably, this can be observed only in
mice fed a SD, whereas a HFD regimen results in hippocampal
resistance to these functional effects of leptin.
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FIGURE 2 | HFD mice are resistant to potentiation of AMPA receptor-mediated evoked excitatory postsynaptic currents (EPSCs) by leptin. (A) Representative traces
showing the amplitude of AMPA receptor-mediated EPSCs before and after application of either vehicle or leptin. The post-treatment response is superimposed to
the baseline response of the same cell, depicted in gray. (B) Leptin induces potentiation of AMPA receptor-mediated evoked EPSCs is SD mice; this effect is
completely abolished in HFD mice (SD-veh n = 11, SD-lep n = 14, HFD-veh n = 12, HFD-lep n = 16; ANOVA-2, diet × treatment interaction, p = 0.002, followed by
Bonferroni post hoc test, ∗∗∗p < 0.001). (C) Representative traces showing AMPA and NMDA receptor-mediated evoked EPSCs (−70 and +40 mV holding
potentials, respectively) before and after application of either vehicle or leptin. Baseline responses are depicted in gray and are superimposed to the post-treatment
response of the same cell. (D) AMPA/NMDA curents ratio of SD mice is enhanced by leptin, whereas HFD mice fail to display this effect (SD-veh n = 10, SD-lep
n = 11, HFD-veh n = 12, HFD-lep n = 10; ANOVA-2, diet × treatment interaction, p = 0.017, followed by Bonferroni post hoc test, ##p = 0.008, ∗∗p = 0.003,
∗∗∗p < 0.001).
Blunted Activation of STAT-3 by Leptin in
HFD Mice
Signal transduction is instrumental to the actuation of leptin
effects on cellular functions. Among the pathways controlled
by the leptin receptor, ObRb, a paramount role is played by
STAT-3 (Plum et al., 2006; Mainardi et al., 2010; Nicolas
et al., 2013). Specifically, phosphorylation of ObRb at 1138Tyr
results in phosphorylation of STAT-3 at 705Tyr. First, we
found that SD mice exhibited increased levels of 1138Tyr-pObRb
45 min after leptin injection (231 ± 14%; Figures 4A,B).
In HFD mice, basal phosphorylation of ObRb was increased
and was unresponsive to modulation by leptin (HFD-veh,
187 ± 35%, HFD-lep, 158 ± 18%; Figures 4A,B). Total
levels of ObRb were not significantly different among the
four experimental groups (Figure 4A and Supplementary
Figure S6A).
Then, we analyzed STAT-3 phosphorylation on 705Tyr, which
in SD-lep mice was 258 ± 26% of SD-veh controls 2 h
after leptin injection (Figures 4C,D). In HFD mice (HFD-veh
group), we observed a significant increase in basal activation
of STAT-3, whose phosphorylation was 187 ± 42% of SD-veh
mice (Figures 4C,D). Moreover, in HFDmice STAT-3 activation
was not significantly affected by leptin injection (HFD-lep,
161 ± 30% vs. HFD-veh, 187 ± 42%; Figures 4D,E). Notably,
no significant differences in the overall expression levels of
STAT-3 were found among the four experimental groups
(Figure 4C and Supplementary Figure S6B). We observed an
analogous trend also for Akt, whose phosphorylation is also
modulated by ObRb (Valladolid-Acebes et al., 2012; Gavello
et al., 2016). Indeed, in SD-lep mice, Akt phosphorylation on
473Ser was increased by leptin to 217 ± 40% of SD-veh controls
(Supplementary Figures S7A,B). On the other hand, HFD-veh
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FIGURE 3 | HFD mice are resistant to leptin-mediated increase in paired-pulse facilitation (PPF). (A) Representative traces showing EPSCs evoked by pair of stimuli
delivered to the Schaffer Collateral (SC) at 100 ms (upper panel) and 200 ms (lower panel) interstimulus intervals (ISIs). The post-treatment response is superimposed
to the baseline response of the same cell, depicted in gray. (B) Leptin treatment increases PPF at 100 ms (SD-veh n = 10, SD-lep n = 10, HFD-veh n = 11, HFD-lep
n = 14; ANOVA-2, diet × treatment interaction, p = 0.022, followed by Bonferroni post hoc test, SD-lep vs. SD-veh, ###p < 0.001, SD-lep vs. HFD-lep, ∗p = 0.013)
and 200 ms (SD-veh n = 10, SD-lep n = 10, HFD-veh n = 11, HFD-lep n = 14; ANOVA-2, diet × treatment interaction, p = 0.009, followed by Bonferroni post hoc
test, SD-lep vs. SD-veh, ##p = 0.005, SD-lep vs. HFD-lep, ∗p = 0.02) ISI in SD mice; in contrast, HFD mice are resistant to the action of leptin on PPF. Baseline and
post-treatment plots have been separated to increase clarity. Both plots are shown on the same range, with no magnification.
mice displayed a significantly higher basal pAkt level, which
was not responsive to leptin (HFD-veh, 153 ± 11%, HFD-lep
148± 16%; Supplementary Figures S7A,B). The total levels of Akt
were not significantly different among groups (Supplementary
Figures S7A,C). Interestingly, loss of STAT-3 activation in HFD
mice could be overcome by injecting an increased dose (5 mg/kg)
of leptin, which led to a significant increase in the levels of
pSTAT-3 (239± 43% of HFD-veh; Supplementary Figure S8).
STAT-3 activation requires its interaction with
phosphorylated ObR and its subsequent detachment from
the receptor (Plum et al., 2006). We analyzed this interaction
by means of co-immunoprecipitation experiments. First, basal
association between STAT-3 and ObRb was significantly lower
in HFD mice than in SD mice (SD-veh, 100 ± 17%; HFD-
veh, 55 ± 8%; Figures 4E,F). In SD-lep mice, STAT-3-ObRb
interaction dropped to 44± 5% of the baseline value observed in
SD-veh mice. On the other hand, in HFD mice, STAT-3-ObRb
interaction was virtually insensitive to leptin and, in the HFD-lep
group, remained to 46 ± 8% of the baseline value observed in
SD-veh mice, which was not significantly different from the
value of the HFD-veh group (Figures 4E,F).
Increased Inhibition of Leptin Signaling in
HFD Mice
A possible mechanism involved in leptin resistance is alteration
of negative feedback signals aimed at suppressing ObRb
activation (Bjorbaek et al., 1998). To ascertain this hypothesis,
we measured the levels of SOCS-3 in the hippocampus of
HFD mice. The SD-lep group showed a significant increase
in SOCS-3 expression 2 h after leptin injection (172 ± 23%,
Figures 5A,B), which was in line with previous literature reports
(Banks et al., 2000). Interestingly, in HFD-fed mice basal levels of
SOCS-3 were higher than in SD-veh mice (HFD-veh, 181± 25%;
Figures 5A,B) and they were not significantly affected by leptin
injection (HFD-lep, 171 ± 17%; Figures 5A,B). Deactivation
of ObRb mainly depends upon its binding by SOCS-3.
Co-immunoprecipitation experiments revealed that, in SD mice,
leptin injection caused this interaction to rise to 159 ± 6%
of baseline (SD-lep vs. SD-veh, Figures 5C,D). In HFD mice,
we observed that basal SOCS-3-ObRb association amounted
to 167 ± 10% of SD mice and this was insensitive to leptin
administration, as we did not find any significant difference
between the HFD-lep and HFD-veh groups (Figures 5C,D).
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FIGURE 4 | Activation of ObRb and STAT-3 is impaired in HFD mice.
(A) Representative images showing immunoblottings for pObRb, ObRb and
α-tubulin. (B) Quantification of pObRb activation (SD-veh n = 4, SD-lep n = 4,
HFD-veh n = 4, HFD-lep n = 4; ANOVA-2, diet × treatment interaction,
p = 0.004, followed by Bonferroni post hoc test, SD-lep vs. SD-veh,
∗∗p = 0.002, SD-veh vs. HFD-veh, ∗p = 0.019, SD-lep vs. HFD-lep,
#p = 0.046). (C) Representative images showing immunoblottings for
pSTAT-3, STAT-3 and α-tubulin. (D) Quantification of pSTAT-3 activation
(SD-veh n = 5, SD-lep n = 6, HFD-veh n = 5, HFD-lep n = 5; ANOVA-2,
diet × treatment interaction, p = 0.003, followed by Bonferroni post hoc test,
SD-lep vs. SD-veh, ∗∗∗p < 0.001, SD-lep vs. HFD-lep, ∗p = 0.019; SD-veh vs.
HFD-veh, #p = 0.029). (E) Representative images showing immunoblottings
for STAT-3 after immunoprecipitation using an anti-ObRb antibody and for the
total protein lysates. (F) Quantification of STAT-3-ObRb interaction from
immunoprecipitates (SD-veh n = 5, SD-lep n = 5, HFD-veh n = 4, HFD-lep
n = 6; ANOVA-2, diet × treatment interaction, p = 0.043, followed by
Bonferroni post hoc test, SD-lep vs. SD-veh, ∗∗p = 0.002; SD-veh vs.
HFD-veh, ∗p = 0.011).
These findings demonstrate that HFD is accompanied by
higher activation of the SOCS-3 inhibitory pathway, along with
loss of its responsiveness to oscillations in leptin levels.
DISCUSSION
Synaptic transmission and plasticity are widely considered
the cellular substrate of learning and memory. Experimental
evidence and clinical studies suggest that diet-dependent
metabolic signals have the potential to impact on cognitive
functions by modulating synaptic function (Morrison, 2009;
Harvey, 2013; Mainardi et al., 2015). In particular, leptin affects
structural plasticity, neurogenesis and synaptic activity (Harvey,
2013; Mainardi et al., 2013; Rubin et al., 2015), thus playing a
neurotrophin-like action exceeding the well-recognized role as a
FIGURE 5 | The SOCS-3 inhibitory pathway is altered in HFD mice.
(A) Representative images showing immunoblottings for SOCS3 and
α-tubulin. (B) Quantification of SOCS-3 levels (SD-veh n = 5, SD-lep n = 5,
HFD-veh n = 5, HFD-lep n = 5; ANOVA-2, diet × treatment interaction,
p = 0.045, followed by Bonferroni post hoc test, SD-lep vs. SD-veh,
∗p = 0.016, SD-veh vs. HFD-veh, ∗∗p = 0.008). (C) Representative images
showing immunoblottings for SOCS-3 after immunoprecipitation using an
anti-ObRb antibody and for the total protein lysates. (D) Quantification of
SOCS-3-ObRb interaction from immunoprecipitates (SD-veh n = 5, SD-lep
n = 5, HFD-veh n = 4, HFD-lep n = 6; ANOVA-2, diet × treatment interaction,
p = 0.012, followed by Bonferroni post hoc test, SD-lep vs. SD-veh,
∗∗p = 0.002; SD-veh vs. HFD-veh, ∗∗∗p < 0.001).
satiety signal. Notably, leptin induces synaptic plasticity with an
age-dependent polarity: LTD is stimulated in juveniles, LTP in
adults (Moult and Harvey, 2011). On the other hand, mounting
evidence points to an action of the dietary style on cognitive
performance. Indeed, rodents fed a HFD display a lower
performance in behavioral tasks involving the hippocampus
(Heyward et al., 2012; Boitard et al., 2014). Thus, we hypothesized
that adult HFD-fed mice could display an impairment in leptin-
driven modulation of the functional substrates of learning and
memory.
First, the results of our work confirm and lend further
support to the effects of leptin on synaptic transmission and
plasticity of hippocampal circuits in SD conditions. Indeed,
we found that leptin enhances spontaneous neurotransmitter
release by increasing sEPSC frequency and both frequency
and amplitude of mEPSCs, consistently with data obtained
in primary hippocampal cultures (Dhar et al., 2014).
Stimulus-evoked synaptic responses of CA1 neurons were
also affected, and this is compatible with induction of LTP-like
postsynaptic phenomena observed in previous work (Moult
and Harvey, 2011). Accordingly, we observed an increase in
the AMPA/NMDA current ratio, with no detectable effect on
NMDA current amplitude, which is likely due to enhanced
AMPA receptor trafficking, as it has been observed in culture
(Moult and Harvey, 2011), and in agreement with the role
of leptin as an ion channel modulator (Gavello et al., 2016).
Moreover, we demonstrate here for the first time an effect on
short-term plasticity, namely PPF. Previous evidence showed
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no effect of leptin on PPF of both excitatory and inhibitory
neurotransmission at short ISIs (Moult et al., 2009; Guimond
et al., 2014). We confirm this finding, using 20 and 50 ms
ISIs. However, when the ISI was increased to 100 or 200 ms,
we detected a clear increase of PPF, an effect that is usually
correlated with a presynaptic site of action (Nicoll and Malenka,
1999). On the other hand, enhanced PPF can also have a
postsynaptic origin, as it has been demonstrated to be a hallmark
feature of EPSCs mediated by GluR2-lacking AMPA receptors
(Liu and Zukin, 2007; Savtchouk and Liu, 2011). Insertion of
GluR2-lacking AMPA receptors has indeed been demonstrated
at SC-CA1 synapses in response to leptin application (Moult
et al., 2010). It is also worth considering that modulation of
PPF selectively at longer ISIs has been demonstrated in various
experimental models and may point to an effect on GABAB
receptor activity (Tsai and Leung, 2006; Gengler et al., 2010). In
addition, hypothalamic GABAergic neurons are one of the most
relevant targets of leptin (Vong et al., 2011; Lee et al., 2015).
The existence of an analogous mechanism in the hippocampus
deserves further investigation in the future. Taken together, our
electrophysiological data demonstrate that leptin potentiates
spontaneous and evoked neurotransmission by acting at both
presynaptic and postsynaptic levels. This dual site of action on
the SC-CA1 pathway is in agreement with the pattern of ObR
expression in the mouse hippocampus, which is widespread,
but peaks in the CA3 area (Caron et al., 2010; Wang et al.,
2015).
The key finding of our patch-clamp experiments is that,
when the same electrophysiological parameters were assessed
in slices obtained from HFD-fed mice, we observed a complete
ineffectiveness of leptin in modulating both spontaneous and
evoked synaptic transmission. Indeed, leptin application under
conditions identical to SD mice failed to modify mEPSCs
and sEPSCs. The same was observed for evoked responses,
i.e., AMPA EPSC amplitude, AMPA/NMDA ratio and PPF.
These data show that HFD mice develop hippocampal resistance
to leptin modulation of both spontaneous and evoked synaptic
transmission.
Leptin exerts its cellular effects by triggering the activation
of intracellular signaling cascades (Coppari and Bjørbæk, 2012).
Thus, we reasoned that an analog of the functional resistance
and insensitivity phenomena described above could exist at
the molecular level. In order to establish a parallelism between
synaptic activity and molecular pathways, we focused on STAT-3
signaling, the primary target of ObRb activation (Coppari and
Bjørbæk, 2012). Leptin administration to SD mice stimulated
ObRb phosphorylation and, with a longer latency, STAT-3
phosphorylation. This event has been shown to be required for
both LTP in adult mice (Zearfoss et al., 2008) and LTD in juvenile
rats (Nicolas et al., 2012), in agreement with the age-dependent
polarity of leptin action on synaptic plasticity (Moult and
Harvey, 2011). Moreover, this action does not require the nuclear
translocation of STAT-3 (Nicolas et al., 2012), which agrees with
the short latency of responses observed in electrophysiological
experiments. On the contrary, HFD mice lost modulation of
ObRb, STAT-3 and Akt phosphorylation in response to leptin. In
addition, HFDmice displayed higher basal levels of hippocampal
ObRb, STAT-3 and Akt activation, which can be correlated to
the sustained increase in plasma leptin levels caused by HFD
(Ahrén et al., 1997), and contributes to delineate the picture of
leptin resistance. These findings are further confirmed by data
from co-immunoprecipitation experiments, showing that HFD
mice fail to exhibit the expected detachment of STAT-3 from
ObR, which is a necessary step for successful signal transduction
(Plum et al., 2006). The partial discrepancy of our data with
those shown in Valladolid-Acebes et al. (2013) can be explained
by the following factors: (i) use of a 45%-calories from fat diet
(we used a 60%-calories from fat diet); (ii) shorter post-injection
dissection time (90 min vs. 120 min); (iii) 1 mg/kg leptin dosage
(we used 3 mg/kg); and (iv) no fasting before leptin injection
(in our study, animals were fasted for 2 h before injection). In
particular, fasting can be important to reset basal leptin levels
(which can vary according to the satiety status of each animal)
and could reduce baseline pSTAT-3 levels in SD-veh mice, thus
unmasking the higher baseline pSTAT-3 in HFD-veh mice we
observed. Finally, it is worth noting that increasing leptin dose
can restore pSTAT-3 activation in HFD mice. This indicates
that, at least in the 8-week HFD model, leptin resistance can be
overcome. On the other hand, protracted HFD, can result, along
with severe obesity, in loss of leptin responsiveness that cannot be
restored by simply increasing the administered dose, also because
of impaired transport across the blood-brain-barrier (Hileman
et al., 2002).
One appealing explanation of the inability of HFD mice
to initiate leptin-dependent signal transduction, despite higher
baseline levels of ObRb phosphorylation, is increased activation
of the negative feedback pathways impinging on this receptor.
Among these, SOCS-3 plays a major role and has been suggested
to be involved in leptin resistance (Balland and Cowley,
2015). Our data support this view, as we observed higher
basal expression of SOCS-3 in HFD-fed mice, along with no
modulation of its levels upon leptin stimulation. On the other
hand, SD-fed mice responded to leptin with a pronounced
increase in SOCS-3 levels. Results from co-IP experiments
confirm this picture, with HFD mice displaying a higher basal
association between SOCS-3 and ObR, which was not responsive
to leptin stimulation. Vice versa, in SD mice, basal SOCS-3-ObR
interaction was low and was dramatically increased by leptin
administration.
Taken together, our results demonstrate that leptin stimulates
neurotransmission, short-term plasticity of the SC-CA1 pathway,
and activation of signal transduction pathways controlled
by ObR. A hyperlypidic diet, however, blunts hippocampal
signaling response to leptin and its functional and molecular
consequences. Our findings also indicate that the hippocampus
shares with the hypothalamus the leptin resistance caused by a
prolonged exposure to HFD.
In addition to providing insight into the mechanisms of leptin
action on the hippocampus and on their disruption in HFD,
our work can be linked to the facts that metabolic alterations
are now recognized as risk factors for Alzheimer’s disease (AD)
(McGuire and Ishii, 2016) and that transgenic mouse models
of AD display altered levels of circulating leptin, along with a
reduction of its effects on hypothalamic neurons (Ishii et al.,
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2014). Thus, either leptin depletion or resistance can contribute
to the neural plasticity deficits typical of AD. In this context,
leptin treatment has been shown to ameliorate amyloid-β toxicity
in vitro (Doherty et al., 2013) and behavioral deficits of transgenic
models of AD (Greco et al., 2010). However, these works
do not provide a strategy for overcoming defective plasticity
and reduced cognitive performance in a condition of leptin
resistance. Further research efforts will, therefore, be aimed at: (i)
clarifying the molecular details of synaptic dysfunction caused by
HFD; and (ii) finding strategies to restore hippocampal response
to leptin.
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